Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?

• Ye Hu,
• Ye Hu,
• Barbie Taylor-Harding,
• Barbie Taylor-Harding,
• Yael Raz,
• Yael Raz,
• Marcela Haro,
• Marcela Haro,
• Maria Sol Recouvreux,
• Maria Sol Recouvreux,
• Enes Taylan,
• Enes Taylan,
• Jenny Lester,
• Joshua Millstein,
• Ann E. Walts,
• Beth Y. Karlan,
• Beth Y. Karlan,
• Sandra Orsulic,
• Sandra Orsulic,
• Sandra Orsulic

Affiliations

Ye Hu

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Ye Hu

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Barbie Taylor-Harding

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Barbie Taylor-Harding

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Yael Raz

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Yael Raz

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Marcela Haro

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Marcela Haro

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Maria Sol Recouvreux

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Maria Sol Recouvreux

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Enes Taylan

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Enes Taylan

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Jenny Lester

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Joshua Millstein

Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States

Ann E. Walts

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Beth Y. Karlan

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Beth Y. Karlan

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States

Sandra Orsulic

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Sandra Orsulic

Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States

Sandra Orsulic

Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States